{"id":1471,"date":"2020-06-01T21:03:23","date_gmt":"2020-06-01T21:03:23","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=1471"},"modified":"2026-02-24T00:01:52","modified_gmt":"2026-02-24T00:01:52","slug":"genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2020\/06\/01\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\/","title":{"rendered":"Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants (Contributed by Dr. Kasper Overbeek)"},"content":{"rendered":"

This study investigated the occurrence of pancreatic cancer in 172 familial melanoma families with a pathogenic CDKN2A <\/em>variant. The CDKN2A<\/em> gene encodes two distinct proteins (p16INK4a and p14ARF) and pathogenic variants can affect one or both. Individuals harbouring variants affecting p16INK4a are considered to be at increased risk for pancreatic cancer, but this study observed no pancreatic cancer in the families with variants affecting only p14ARF. Therefore, individuals with variants affecting only p14ARF should not be considered at increased risk for pancreatic cancer, and should not be included in pancreatic cancer surveillance programmes. (https:\/\/jmg.bmj.com\/content\/early\/2020\/06\/01\/jmedgenet-2019-106562<\/a> )
\n\"\"<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

This study investigated the occurrence of pancreatic cancer in 172 familial melanoma families with a pathogenic CDKN2A variant. The CDKN2A gene encodes two distinct proteins (p16INK4a and p14ARF) and pathogenic variants can affect one or both. Individuals harbouring variants affecting p16INK4a are considered to be at increased risk for pancreatic cancer, but this study observed […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1471","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nGenotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants (Contributed by Dr. Kasper Overbeek) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2020\/06\/01\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants (Contributed by Dr. Kasper Overbeek) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"This study investigated the occurrence of pancreatic cancer in 172 familial melanoma families with a pathogenic CDKN2A variant. The CDKN2A gene encodes two distinct proteins (p16INK4a and p14ARF) and pathogenic variants can affect one or both. Individuals harbouring variants affecting p16INK4a are considered to be at increased risk for pancreatic cancer, but this study observed [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2020\/06\/01\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-01T21:03:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-24T00:01:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.bmj.com\/jmg\/files\/2020\/06\/Figure1-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2274\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/06\\\/01\\\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/06\\\/01\\\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants (Contributed by Dr. Kasper Overbeek)\",\"datePublished\":\"2020-06-01T21:03:23+00:00\",\"dateModified\":\"2026-02-24T00:01:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/06\\\/01\\\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\\\/\"},\"wordCount\":129,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/06\\\/01\\\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2020\\\/06\\\/Figure1-266x300.jpg\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/06\\\/01\\\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/06\\\/01\\\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/06\\\/01\\\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\\\/\",\"name\":\"Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants (Contributed by Dr. Kasper Overbeek) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/06\\\/01\\\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/06\\\/01\\\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2020\\\/06\\\/Figure1-266x300.jpg\",\"datePublished\":\"2020-06-01T21:03:23+00:00\",\"dateModified\":\"2026-02-24T00:01:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/06\\\/01\\\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/06\\\/01\\\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/06\\\/01\\\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2020\\\/06\\\/Figure1-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2020\\\/06\\\/Figure1-scaled.jpg\",\"width\":2274,\"height\":2560},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/06\\\/01\\\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants (Contributed by Dr. Kasper Overbeek)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants (Contributed by Dr. Kasper Overbeek) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2020\/06\/01\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\/","og_locale":"en_US","og_type":"article","og_title":"Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants (Contributed by Dr. Kasper Overbeek) - JMG Contact blog","og_description":"This study investigated the occurrence of pancreatic cancer in 172 familial melanoma families with a pathogenic CDKN2A variant. The CDKN2A gene encodes two distinct proteins (p16INK4a and p14ARF) and pathogenic variants can affect one or both. Individuals harbouring variants affecting p16INK4a are considered to be at increased risk for pancreatic cancer, but this study observed [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2020\/06\/01\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\/","og_site_name":"JMG Contact blog","article_published_time":"2020-06-01T21:03:23+00:00","article_modified_time":"2026-02-24T00:01:52+00:00","og_image":[{"width":2274,"height":2560,"url":"https:\/\/blogs.bmj.com\/jmg\/files\/2020\/06\/Figure1-scaled.jpg","type":"image\/jpeg"}],"author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2020\/06\/01\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2020\/06\/01\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants (Contributed by Dr. Kasper Overbeek)","datePublished":"2020-06-01T21:03:23+00:00","dateModified":"2026-02-24T00:01:52+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2020\/06\/01\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\/"},"wordCount":129,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2020\/06\/01\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2020\/06\/Figure1-266x300.jpg","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2020\/06\/01\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2020\/06\/01\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\/","url":"https:\/\/blogs.bmj.com\/jmg\/2020\/06\/01\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\/","name":"Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants (Contributed by Dr. Kasper Overbeek) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2020\/06\/01\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\/#primaryimage"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2020\/06\/01\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2020\/06\/Figure1-266x300.jpg","datePublished":"2020-06-01T21:03:23+00:00","dateModified":"2026-02-24T00:01:52+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2020\/06\/01\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2020\/06\/01\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/2020\/06\/01\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\/#primaryimage","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2020\/06\/Figure1-scaled.jpg","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2020\/06\/Figure1-scaled.jpg","width":2274,"height":2560},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2020\/06\/01\/genotype-phenotype-correlations-for-pancreatic-cancer-risk-in-dutch-melanoma-families-with-pathogenic-cdkn2a-variants\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants (Contributed by Dr. Kasper Overbeek)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1471","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=1471"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1471\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=1471"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=1471"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=1471"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}